{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:04:30Z","timestamp":1772881470471,"version":"3.50.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1097\/mph.0b013e318279e5ca","type":"journal-article","created":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T08:11:12Z","timestamp":1358496672000},"page":"e178-e182","source":"Crossref","is-referenced-by-count":5,"title":["Irreversible Leukoencephalopathy After Reduced-intensity Stem Cell Transplantation in a Dyskeratosis Congenita Patient With TINF2 Mutation"],"prefix":"10.1097","volume":"35","author":[{"given":"Takeshi","family":"Isoda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Mitsuiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teppei","family":"Ohkawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Setsuko","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Ono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Tomizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiko","family":"Kajiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Morio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuki","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-32-20210227","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2141.2009.07598.x","article-title":"Advances in the understanding of dyskeratosis congenita.","volume":"145","author":"Walne","year":"2009","journal-title":"Br J Haematol"},{"key":"R2-32-20210227","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1182\/blood-2007-08-019729","article-title":"Telomere maintenance and human bone marrow failure.","volume":"111","author":"Calado","year":"2008","journal-title":"Blood"},{"key":"R3-32-20210227","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1182\/blood-2007-02-075598","article-title":"Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita.","volume":"110","author":"Alter","year":"2007","journal-title":"Blood"},{"key":"R4-32-20210227","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/asheducation-2011.1.480","article-title":"Dyskeratosis congenita.","volume":"2011","author":"Dokal","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R5-32-20210227","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ajhg.2007.10.004","article-title":"TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita.","volume":"82","author":"Savage","year":"2008","journal-title":"Am J Hum Genet"},{"key":"R6-32-20210227","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1182\/blood-2008-05-153445","article-title":"TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes.","volume":"112","author":"Walne","year":"2008","journal-title":"Blood"},{"key":"R7-32-20210227","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1399-3046.2007.00721.x","article-title":"Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.","volume":"11","author":"de la Fuente","year":"2007","journal-title":"Pediatr Transplant"},{"key":"R9-32-20210227","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.bmt.1705839","article-title":"Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan.","volume":"40","author":"Amarasinghe","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"R10-32-20210227","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/nprot.2006.263","article-title":"Flow cytometry and FISH to measure the average length of telomeres (flow FISH).","volume":"1","author":"Baerlocher","year":"2006","journal-title":"Nat Protoc"},{"key":"R11-32-20210227","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1538-7836.2006.02267.x","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial.","volume":"5","author":"Saito","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"suppl 1","key":"R12-32-20210227","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1538-7836.2011.04319.x","article-title":"Thrombomodulin: protectorate God of the vasculature in thrombosis and inflammation.","volume":"9","author":"Ito","year":"2011","journal-title":"J Thromb Haemost"},{"key":"R13-32-20210227","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1046\/j.1365-2141.1998.00949.x","article-title":"Unusual complications after bone marrow transplantation for dyskeratosis congenita.","volume":"103","author":"Rocha","year":"1998","journal-title":"Br J Haematol"},{"key":"R14-32-20210227","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/bmt.2010.65","article-title":"Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita.","volume":"46","author":"Dietz","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"R15-32-20210227","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1182\/blood-2009-03-207563","article-title":"A phase II pilot study of tacrolimussirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens.","volume":"115","author":"Rodriguez","year":"2010","journal-title":"Blood"},{"key":"R16-32-20210227","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3174\/ajnr.A0928","article-title":"Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.","volume":"29","author":"Bartynski","year":"2008","journal-title":"Am J Neuroradiol"},{"key":"R17-32-20210227","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/pbc.20703","article-title":"Posterior reversible encephalopathy syndrome in children with cancer.","volume":"48","author":"Morris","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R18-32-20210227","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/pbc.21688","article-title":"Encephalopathy syndrome in children with hemato-oncological disorders is not always posterior and reversible.","volume":"51","author":"Lucchini","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R19-32-20210227","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/pbc.20731","article-title":"A syndrome of irreversible leukoencephalopathy following pediatric allogeneic bone marrow transplantation.","volume":"48","author":"Minn","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R20-32-20210227","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1016\/j.transproceed.2008.06.038","article-title":"Endothelial injury, an intriguing effect of methotrexate and cyclophosphamide during hematopoietic stem cell transplantation in mice.","volume":"40","author":"Zeng","year":"2008","journal-title":"Transplant Proc"},{"key":"R21-32-20210227","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/109980040000200102","article-title":"Methotrexate causes apoptosis in postmitotic endothelial cells.","volume":"2","author":"Merkle","year":"2000","journal-title":"Biol Res Nurs"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0b013e318279e5ca","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:14:02Z","timestamp":1620965642000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201305000-00032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e318279e5ca","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}